Wound Care (Pharmacies) - BRICS

  • BRICS
  • Revenue in the Wound Care market is projected to reach US$252.50m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.44%, resulting in a market volume of US$258.10m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.08 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in BRICS is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the overall growth of the market. Customer preferences in the Wound Care (Pharmacies) market in BRICS are shifting towards more advanced and innovative products. Customers are increasingly seeking wound care products that are effective, convenient to use, and have minimal side effects. This has led to a rise in demand for products such as advanced dressings, wound closure devices, and wound healing agents. Additionally, customers are also looking for products that are affordable and easily accessible, driving the growth of the market in pharmacies. Trends in the market are also driving the growth of the Wound Care (Pharmacies) market in BRICS. One major trend is the increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, which has created a growing need for effective wound care products. Another trend is the rising awareness about the importance of wound care and the availability of advanced wound care products in pharmacies. This has led to an increase in the number of customers seeking professional advice and purchasing wound care products from pharmacies. Local special circumstances in each BRICS country also play a role in the development of the Wound Care (Pharmacies) market. For example, in Brazil, the high incidence of chronic wounds, coupled with the country's large population, has created a significant demand for wound care products in pharmacies. In Russia, the growing elderly population and the increasing prevalence of chronic diseases have contributed to the growth of the market. In India and China, the rising healthcare expenditure and improving healthcare infrastructure have led to an increase in the availability and accessibility of wound care products in pharmacies. In South Africa, the high prevalence of HIV/AIDS and diabetes has fueled the demand for wound care products. Underlying macroeconomic factors also influence the growth of the Wound Care (Pharmacies) market in BRICS. Factors such as economic growth, increasing disposable income, and improving healthcare systems contribute to the overall development of the market. As the economies of BRICS countries continue to grow, more people are able to afford wound care products and seek proper medical treatment, driving the demand for such products in pharmacies. In conclusion, the Wound Care (Pharmacies) market in BRICS is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards advanced and innovative products, increasing prevalence of chronic wounds, rising awareness about wound care, and improving healthcare systems all contribute to the growth of the market in pharmacies.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)